Firms

Founded

—

Type

Venture capital

Team

No team members on record yet.

Co-investing

ARCH Venture Partners

• Gate Bioscience$65M · 2025-11-13
• Gate Bio$60M · 2023-11-01
• Gate Bioscience$60M · 2023-11-01
• Kythera Biopharmaceuticals$37M · 2011-09-19
• Gate Bio$65M · Unknown date

GV

• Gate Bioscience$65M · 2025-11-13
• Gate Bio$60M · 2023-11-01
• Gate Bioscience$60M · 2023-11-01
• Gate Bio$65M · Unknown date

Eli Lilly and Company

• Gate Bioscience$65M · 2025-11-13
• Gate Bio$65M · Unknown date

Forbion

• Gate Bioscience$65M · 2025-11-13
• Gate Bio$65M · Unknown date

Vineeta Agarwala

• Gate Bioscience$65M · 2025-11-13
• Gate Bioscience$60M · 2023-11-01

SHOW MORE

Investments

$65M2025-11-13	Gate Bioscience	ARCH Venture Partners, GV, Forbion, Versant Ventures, Eli Lilly and Company, Vineeta Agarwala
$60M2023-11-01	Gate Bio	Versant Ventures, Andreessen Horowitz, ARCH Venture Partners, GV
$60M2023-11-01	Gate Bioscience	ARCH Venture Partners, GV, Versant Ventures, Vineeta Agarwala
$107M2022-11-15	Jnana Therapeutics	Bain Capital, Polaris Partners, RA Capital Management, Avon Ventures, Versant Ventures, Pfizer Ventures
$37M2011-09-19	Kythera Biopharmaceuticals	ARCH Venture Partners, Altitude Life Science Ventures, Versant Ventures, JAFCO Group Co., Ltd.
$65MUnknown date	Gate Bio	ARCH Venture Partners, GV, Forbion, Versant Ventures, Eli Lilly and Company, Andreessen Horowitz (a16z) Bio + Health

SHOW MORE